Free Newsletter
Pharma contributions drop as PACs begin speaking Democrat
The year 2008 saw some $15 million in lobbying contributions from pharmaceutical manufacturers, with individual contributions about half that of political action committees. The total split 52 percent for Republicans and 48 percent for Democrats. 2010 is expected to see a big dropoff-to just $1.4 million, with the split changing to 53 percent for Democrats, 47 percent for Republicans. The dropoff marks the reversal of a growth trend that began in 2004, when contributions totaled about $10 million. 2004 was also a huge dropoff, from $22 million in 2002, of which 80% went to Republicans. Analysis
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession




